Savonix, a company that designs tools for cognitive testing, has introduced a new assessment available via healthcare providers using any mobile device.
Savonix Mobile will eliminate the need for time-consuming and expensive pen-and-paper exams to screen for cognitive function, the company said.
According to Savonix, the solution, which expands the utility of cognitive data, delivers usable and scalable data for brain function in domains such as working memory, executive function and impulse control.
“We are addressing a critical challenge in healthcare by solving how we assess mental health, specifically the cognitive and emotional function of patients on a large scale, despite limited budgets and insufficient numbers of trained specialists,” said Mylea Charvat, founder of Savonix.
“Savonix has developed mobile tools that utilize critical cognitive data to better understand patients’ health, identify those at risk via Health Risk Assessments and improve outcomes at the individual and systems level in healthcare – all while saving time and money.”
Savonix was formed to build an affordable and accessible tool for cognitive testing. The company has created a way for providers, payers and patients to easily incorporate cognitive data in treatment planning and decisions at a fraction of the cost of traditional legacy testing.
As well as digitizing cognitive tests, Savonix solves a critical piece of the patient care continuum. Studies have shown that cognition is a major predictor of outcomes in disorders as varied as depression, diabetes and Chronic Obstructive Pulmonary Disease (COPD).
"Traditional cognitive testing is a lengthy and inefficient process. With Savonix we have found a simple and cost-effective way to gauge cognitive function as well as organize and store this data at the population level,” said Dov Biran, CEO of Fitango Health.
“As a population health management platform, the data Savonix’s technology delivers is invaluable. We’ve integrated their assessment into our workflows and will save significant time and money while improving patient care.”
Savonix, US, Technology, IT, Insurance, Healthcare, Data analysis, Cognitive data, Chronic Obstructive Pulmonary Disease, Savonix Mobile, Risk management